Efficacy of Ultrasound-guided Transverse Carpal Ligament Release for Carpal Tunnel Syndrome
Comparison of Ultrasound-guided Transverse Carpal Ligament Needle Release Via Different Approaches for Patients With Mild-to-moderate Carpal Tunnel Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
Carpal tunnel syndrome (CTS) is one of the most common peripheral nerve entrapment neuropathies, and it is characterized by pain, numbness, tingling, and weakness in the regions innervated by the median nerve (MN). CTS is believed to result from compression of the MN as it passes through the narrowed carpal tunnel with regard to gradual ischemia and fibrosis.Ultrasound-guided needle release of transverse carpal ligament(TCL) is an effective method to decompress the carpal.There are two main approaches to perform the release, short-axis or long-axis. However, there is no consensus about the optimal strategy.Thus, this study aimed to compare the efficacy of these two approaches for patients with mild-to-moderate CTS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedFirst Submitted
Initial submission to the registry
February 1, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedFebruary 12, 2024
February 1, 2024
3 years
February 1, 2024
February 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
visual analogue scale(VAS) scores
The VAS scores is the most common tool to assess the level of pain. Possible scores range from 0(no pain) to 10(worst possible pain).
Baseline as well as 1 month, 3 month and 6 months after injection.
Secondary Outcomes (2)
Boston carpal tunnel syndrome questionnaire(BCTQ)
Baseline as well as 1 month, 3 month and 6 months after injection.
cross-sectional area(CSA) of the median nerve
Baseline as well as 1 month, 3 month and 6 months after injection.
Study Arms (2)
long-axis group
EXPERIMENTALThe patients in the long-axis group received one session of ultrasound-guided long-axis needle release of transverse carpal ligament.
short-axis group
ACTIVE COMPARATORThe patients in the short-axis group received one session of ultrasound-guided short-axis needle release of transverse carpal ligament.
Interventions
The participants received one session of ultrasound-guided long-axis TCL needle release.
The participants received one session of ultrasound-guided long-axis TCL needle release.
Eligibility Criteria
You may qualify if:
- years old
- typical clinical signs of CTS present for at least three months, including pain, numbness, and tingling of the hands
- positive Phalen or Tinel sign
- electrophysiological parameters supportive of mild to moderate CTS
- high-resolution ultrasonography demonstrated MN compression at the carpal.
You may not qualify if:
- bifid MN or bilateral CTS
- pregnancy
- disorders such as rheumatic immune diseases, chronic renal failure, diabetes mellitus, hypothyroidism and other systemic diseases
- any accompanying disorder that could mimic CTS, such as thoracic outlet syndrome, cervical radiculopathy, polyneuropathy, proximal median nerve entrapment
- history of carpal tunnel surgery or injection into the affected carpal tunnel
- CTS caused by trauma, surgery, intracarpal lesions, or MN lesions malignant tumors or severe cardiorespiratory diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University People's Hospital
Beijing, Beijing Municipality, 100032, China
Related Publications (3)
Wipperman J, Goerl K. Carpal Tunnel Syndrome: Diagnosis and Management. Am Fam Physician. 2016 Dec 15;94(12):993-999.
PMID: 28075090BACKGROUNDOrhurhu V, Orman S, Peck J, Urits I, Orhurhu MS, Jones MR, Manchikanti L, Kaye AD, Odonkor C, Hirji S, Cornett EM, Imani F, Varrassi G, Viswanath O. Carpal Tunnel Release Surgery- A Systematic Review of Open and Endoscopic Approaches. Anesth Pain Med. 2020 Dec 26;10(6):e112291. doi: 10.5812/aapm.112291. eCollection 2020 Dec.
PMID: 34150584BACKGROUNDPetrover D, Richette P. Treatment of carpal tunnel syndrome : from ultrasonography to ultrasound guided carpal tunnel release. Joint Bone Spine. 2018 Oct;85(5):545-552. doi: 10.1016/j.jbspin.2017.11.003. Epub 2017 Nov 16.
PMID: 29154980BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jiaan Zhu, Dr
Peking University People's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 1, 2024
First Posted
February 9, 2024
Study Start
January 1, 2020
Primary Completion
December 30, 2022
Study Completion
December 30, 2023
Last Updated
February 12, 2024
Record last verified: 2024-02